Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral sclerosis (ALS), with high diagnostic and prognostic accuracy, according ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced ...
WEST PALM BEACH, FLORIDA — When evaluated at 3 or 12 months, serum neurofilament light chain (sNfL) levels were predictive of new or enlarging T2 lesions in patients with multiple sclerosis (MS) ...
Early detection of Alzheimer's disease-related changes in Parkinson's disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated tau (p-tau) ...
Examining patient preferences in the delivery of healthcare education. Comparative analysis of efficacy and safety profiles between conventional pegfilgrastim and its biosimilar agents in patients ...
Siemens Healthineers AG has received CE mark for a neurofilament light chain assay to help with the early diagnosis of multiple sclerosis and aid in predicting the risk of relapse in patients ...
MONTREAL — Levels of neurofilament light chain (Nfl) may be a biomarker of chemotherapy-induced peripheral neurotoxicity (PIPN), new research suggests. Investigators found Nfl levels increased in ...
Please provide your email address to receive an email when new articles are posted on . EMPHASIS study included 258 persons with MS given vidofludimus calcium or placebo for 24 weeks. Results show ...
Please provide your email address to receive an email when new articles are posted on . 31 patients, with and without mild cognitive impairment, underwent overnight polysomnogram with blood draw for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results